Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated to v3.6.3. The page also removes references to Ovarian cancer, related topics:, and MedlinePlus Genetics, reflecting a minor cleanup of topics displayed on the page.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded the topic tag 'Ovarian cancer' and linked 'MedlinePlus Genetics' as a related topic. Updated the site revision from v3.6.0 to v3.6.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new label No longer looking for participants was added to the study page, indicating that recruitment for this trial has ended. Additionally, several navigation and help sections were added or removed to update the page structure.SummaryDifference0.4%

- Check32 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a back-end or front-end update. The change reflects an update to the page's underlying versioning rather than content changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedA new page revision label Revision: v3.5.4 has been added, replacing the prior Revision: v3.5.3. This indicates the page has been updated to a newer version.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page footer’s revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.